CA2003535A1 - Methode et appareil pour detecter et enlever les plaques atherosclerotiques dans les arteres au moyen du laser - Google Patents
Methode et appareil pour detecter et enlever les plaques atherosclerotiques dans les arteres au moyen du laserInfo
- Publication number
- CA2003535A1 CA2003535A1 CA 2003535 CA2003535A CA2003535A1 CA 2003535 A1 CA2003535 A1 CA 2003535A1 CA 2003535 CA2003535 CA 2003535 CA 2003535 A CA2003535 A CA 2003535A CA 2003535 A1 CA2003535 A1 CA 2003535A1
- Authority
- CA
- Canada
- Prior art keywords
- tissue
- spectrum
- fluorescent
- intensity
- peak
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 208
- 210000001367 artery Anatomy 0.000 title description 8
- 238000001228 spectrum Methods 0.000 claims abstract description 424
- 238000011282 treatment Methods 0.000 claims abstract description 110
- 230000005284 excitation Effects 0.000 claims abstract description 34
- 230000002159 abnormal effect Effects 0.000 claims abstract description 31
- 210000004204 blood vessel Anatomy 0.000 claims abstract description 11
- 210000001519 tissue Anatomy 0.000 claims description 464
- 238000012360 testing method Methods 0.000 claims description 117
- 239000002131 composite material Substances 0.000 claims description 111
- 239000008280 blood Substances 0.000 claims description 37
- 210000004369 blood Anatomy 0.000 claims description 35
- 150000003278 haem Chemical class 0.000 claims description 34
- 238000010521 absorption reaction Methods 0.000 claims description 30
- 238000004458 analytical method Methods 0.000 claims description 30
- 238000010304 firing Methods 0.000 claims description 29
- 230000008569 process Effects 0.000 claims description 29
- 238000004422 calculation algorithm Methods 0.000 claims description 26
- 238000002679 ablation Methods 0.000 claims description 18
- 239000013307 optical fiber Substances 0.000 claims description 10
- 230000003595 spectral effect Effects 0.000 claims description 10
- 238000001356 surgical procedure Methods 0.000 claims description 10
- 238000010606 normalization Methods 0.000 claims description 4
- 238000012935 Averaging Methods 0.000 claims description 3
- 230000001678 irradiating effect Effects 0.000 claims description 3
- 239000000835 fiber Substances 0.000 abstract description 58
- 230000003287 optical effect Effects 0.000 abstract description 30
- 238000013147 laser angioplasty Methods 0.000 abstract description 9
- 230000003143 atherosclerotic effect Effects 0.000 abstract description 6
- 230000009102 absorption Effects 0.000 description 29
- 239000000126 substance Substances 0.000 description 24
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 20
- 238000001727 in vivo Methods 0.000 description 20
- 239000000463 material Substances 0.000 description 17
- 238000000338 in vitro Methods 0.000 description 15
- 239000000523 sample Substances 0.000 description 14
- 230000008859 change Effects 0.000 description 10
- 238000012545 processing Methods 0.000 description 10
- 238000002604 ultrasonography Methods 0.000 description 10
- 230000006378 damage Effects 0.000 description 8
- 102000001554 Hemoglobins Human genes 0.000 description 7
- 108010054147 Hemoglobins Proteins 0.000 description 7
- 208000007536 Thrombosis Diseases 0.000 description 7
- 238000002399 angioplasty Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 238000012937 correction Methods 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 230000018109 developmental process Effects 0.000 description 6
- 238000002189 fluorescence spectrum Methods 0.000 description 6
- 206010003210 Arteriosclerosis Diseases 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 238000000295 emission spectrum Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 238000013480 data collection Methods 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 238000002583 angiography Methods 0.000 description 3
- 210000000709 aorta Anatomy 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 230000031700 light absorption Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 208000021328 arterial occlusion Diseases 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000005670 electromagnetic radiation Effects 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000000608 laser ablation Methods 0.000 description 2
- 238000001499 laser induced fluorescence spectroscopy Methods 0.000 description 2
- 238000013532 laser treatment Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- UJKPHYRXOLRVJJ-MLSVHJFASA-N CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C Chemical compound CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C UJKPHYRXOLRVJJ-MLSVHJFASA-N 0.000 description 1
- 206010012426 Dermal cyst Diseases 0.000 description 1
- 241000479907 Devia <beetle> Species 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 101100284769 Drosophila melanogaster hemo gene Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010072052 Plaque shift Diseases 0.000 description 1
- 235000006629 Prosopis spicigera Nutrition 0.000 description 1
- 240000000037 Prosopis spicigera Species 0.000 description 1
- XDXHAEQXIBQUEZ-UHFFFAOYSA-N Ropinirole hydrochloride Chemical compound Cl.CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2 XDXHAEQXIBQUEZ-UHFFFAOYSA-N 0.000 description 1
- 206010053648 Vascular occlusion Diseases 0.000 description 1
- 206010068149 Vessel perforation Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000005314 correlation function Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 102000018146 globin Human genes 0.000 description 1
- 108060003196 globin Proteins 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960003569 hematoporphyrin Drugs 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000012623 in vivo measurement Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000002430 laser surgery Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000012067 mathematical method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000001579 optical reflectometry Methods 0.000 description 1
- JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
- 230000001443 photoexcitation Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000002463 transducing effect Effects 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
- A61B18/24—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter
- A61B18/245—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter for removing obstructions in blood vessels or calculi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00137—Details of operation mode
- A61B2017/00154—Details of operation mode pulsed
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Otolaryngology (AREA)
- Electromagnetism (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Laser Surgery Devices (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27458388A | 1988-11-22 | 1988-11-22 | |
| US274,583 | 1988-11-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2003535A1 true CA2003535A1 (fr) | 1990-05-22 |
Family
ID=23048795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2003535 Abandoned CA2003535A1 (fr) | 1988-11-22 | 1989-11-21 | Methode et appareil pour detecter et enlever les plaques atherosclerotiques dans les arteres au moyen du laser |
Country Status (2)
| Country | Link |
|---|---|
| CA (1) | CA2003535A1 (fr) |
| WO (1) | WO1990005563A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0449883B1 (fr) * | 1988-12-21 | 1996-01-31 | Massachusetts Institute Of Technology | Procede de fluorescence de tissus induite par laser |
| US5452723A (en) * | 1992-07-24 | 1995-09-26 | Massachusetts Institute Of Technology | Calibrated spectrographic imaging |
| US6658850B1 (en) | 2002-11-05 | 2003-12-09 | General Electric Company | Radio frequency communications network for power plant control systems |
| EP2361549A3 (fr) * | 2005-09-30 | 2012-05-02 | Cornova, Inc. | Système d'analyse et de traitement d'une lumière de corps |
| WO2010045437A2 (fr) | 2008-10-15 | 2010-04-22 | Cornova, Inc. | Systèmes et procédés pour analyser et traiter une lumière corporelle occluse |
| US10052154B2 (en) * | 2014-10-01 | 2018-08-21 | Verily Life Sciences Llc | System and method for fluorescence-based laser ablation |
| AU2016274690B2 (en) * | 2015-06-10 | 2020-05-21 | Boston Scientific Scimed, Inc. | Bodily substance detection by evaluating photoluminescent response to excitation radiation |
| CN113533305A (zh) * | 2021-07-06 | 2021-10-22 | 长江大学 | 一种用于激光治疗血管瘤的效果评价方法及装置 |
| CN117095806B (zh) * | 2023-10-19 | 2023-12-15 | 邦士医疗科技股份有限公司 | 一种手术室医疗器械的质量管理系统 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4479499A (en) * | 1982-01-29 | 1984-10-30 | Alfano Robert R | Method and apparatus for detecting the presence of caries in teeth using visible light |
| JPS5940830A (ja) * | 1982-08-31 | 1984-03-06 | 浜松ホトニクス株式会社 | レ−ザ光パルスを用いた癌の診断装置 |
| US4669467A (en) * | 1985-03-22 | 1987-06-02 | Massachusetts Institute Of Technology | Mode mixer for a laser catheter |
| US4862886A (en) * | 1985-05-08 | 1989-09-05 | Summit Technology Inc. | Laser angioplasty |
| DE3542167A1 (de) * | 1985-11-29 | 1987-06-04 | Wolfgang Prof Dr Lohmann | Verfahren zur messung der augen-linsen-truebung und anordnung zur durchfuehrung des verfahrens |
| US4785806A (en) * | 1987-01-08 | 1988-11-22 | Yale University | Laser ablation process and apparatus |
-
1989
- 1989-11-21 CA CA 2003535 patent/CA2003535A1/fr not_active Abandoned
- 1989-11-22 WO PCT/US1989/005295 patent/WO1990005563A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1990005563A1 (fr) | 1990-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3752693B2 (ja) | レーザ誘導微分正規化蛍光式癌診断方法及び装置 | |
| Vo‐Dinh et al. | In vivo cancer diagnosis of the esophagus using differential normalized fluorescence (DNF) indices | |
| JP3234249B2 (ja) | 近赤外線検出装置および外科用装置 | |
| US5201318A (en) | Contour mapping of spectral diagnostics | |
| US6208887B1 (en) | Catheter-delivered low resolution Raman scattering analyzing system for detecting lesions | |
| Deckelbaum et al. | Discrimination of normal and atherosclerotic aorta by laser‐induced fluorescence | |
| JP4406091B2 (ja) | 生体および生体器官の光力学的処理装置 | |
| US5022757A (en) | Heterodyne system and method for sensing a target substance | |
| Kapadia et al. | Laser-induced fluorescence spectroscopy of human colonic mucosa: detection of adenomatous transformation | |
| US5701902A (en) | Spectroscopic burn injury evaluation apparatus and method | |
| EP1644867B1 (fr) | Systeme et methode de diagnostic de détection optique des régions suspicieuses dans un échantillon de tissu | |
| US4981138A (en) | Endoscopic fiberoptic fluorescence spectrometer | |
| EP0449883B1 (fr) | Procede de fluorescence de tissus induite par laser | |
| US8060187B2 (en) | Near-infrared spectroscopic analysis of blood vessel walls | |
| Deckelbaum et al. | Fluorescence spectroscopy guidance of laser ablation of atherosclerotic plaque | |
| AU707237B2 (en) | Method and apparatus for diagnosis skin lesions | |
| JP2003102672A (ja) | 病変等の対象部位を自動的に検知かつ治療または採取する方法およびその装置 | |
| US20040044287A1 (en) | Identification of human tissue using optical spectroscopy | |
| US7486985B2 (en) | Near-infrared spectroscopic analysis of blood vessel walls | |
| Richards-Kortum et al. | 476 nm excited laser-induced fluorescence spectroscopy of human coronary arteries: applications in cardiology | |
| CA2003535A1 (fr) | Methode et appareil pour detecter et enlever les plaques atherosclerotiques dans les arteres au moyen du laser | |
| Bartorelli et al. | In vivo human atherosclerotic plaque recognition by laser-excited fluorescence spectroscopy | |
| Cutruzzola et al. | Change in laser‐induced arterial fluorescence during ablation of atherosclerotic plaque | |
| Perk et al. | Laser induced fluorescence identification of sinoatrial and atrioventricular nodal conduction tissue | |
| Deckelbaum et al. | In-vivo fluorescence spectroscopy of normal and atherosclerotic arteries |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |